Pharma Journalist 9038 posts 0 comments

ReForm Biologics LLC, a pharmaceutical technology company developing innovative platforms to improve biologic formulations and MilliporeSigma announced a global license agreement and…
Read More...

Catalent, Inc. announced that it had completed its acquisition of MaSTherCell Global Inc., positioning Catalent as a premier technology, development and manufacturing partner for…
Read More...

Biohaven Pharmaceutical Holding Company Ltd. reported negative topline results from its Phase 3 clinical trial evaluating troriluzole compared to placebo for the treatment of patients…
Read More...

Eli Lilly and Company announced that the analysis performed by Washington University School of Medicine in the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study showed…
Read More...

Kite, a Gilead Company announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted Priority Review designation for…
Read More...

SMi Reports: The AI in Drug Discovery conference will feature a panel discussion with panellists from Novartis, OMass Therapeutics, Domaineux and AstraZeneca. SMi Group’s inaugural AI…
Read More...

With just three weeks until the RAS- Targeted Drug Discovery Summit Europe, don’t miss this unique opportunity to present your research to 80+ attendees from Europe’s large pharma and…
Read More...

BOSTON, January 2020 – Hansonwade will present the 4th NASH Summit in Boston from May 4-7, 2020. For its anticipated return, the forum is set to widen its program and congregate over…
Read More...

SMi reports: The Highly Potent Active Pharmaceutical Ingredients conference will explore real-world examples of PBD payload synthesis, manufacture of oncology products and design of ADC…
Read More...

The Vegetation Management business within Bayer CropScience LP, announces the label for its latest product. Invora Herbicide has received federal approval from the U.S. Environmental…
Read More...